Sign up to save your podcasts
Or
Share The Evolution of Incretins – A Revolution in Diabetes Management?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Evolution of Incretins – A Revolution in Diabetes Management?
The expanding world of glucagon-like peptide-1 (GLP-1) receptor antagonism. What do these developments mean for clinical practice?
Credit available for this activity expires: 6/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001235?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape Podcasts
4
77 ratings
The expanding world of glucagon-like peptide-1 (GLP-1) receptor antagonism. What do these developments mean for clinical practice?
Credit available for this activity expires: 6/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001235?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current
View all
Merriam-Webster's Word of the Day
1,258 Listeners
NEJM This Week
318 Listeners
JAMA Clinical Reviews
498 Listeners
Neurology® Podcast
299 Listeners
Science Quickly
1,382 Listeners
HBR IdeaCast
161 Listeners
This Week in Cardiology
884 Listeners
The Bob Harrington Show
14 Listeners
One-on-One with Eric Topol
16 Listeners
Mayo Clinic Talks
296 Listeners
The Curbsiders Internal Medicine Podcast
3,341 Listeners
The Peter Attia Drive
8,507 Listeners
Annals On Call Podcast
193 Listeners
The Clinical Problem Solvers
512 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Medicine and the Machine
60 Listeners
Keeping Current CME
28 Listeners
Cardionerds: A Cardiology Podcast
428 Listeners